Country: United States
Sector: Health Care
Website: nanAbsci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion